Unicycive Therapeutics In...

NASDAQ: UNCY · Real-Time Price · USD
5.99
-0.22 (-3.54%)
At close: Jun 26, 2025, 3:59 PM
6.20
3.50%
Pre-market: Jun 27, 2025, 06:41 AM EDT

Unicycive Therapeutics Statistics

Share Statistics

Unicycive Therapeutics has 120.63M shares outstanding. The number of shares has increased by -0.03% in one year.

120.63M
-0.03%
0%
69.37%
100.03M
20
n/a

Short Selling Information

The latest short interest is 356.9K, so 0.3% of the outstanding shares have been sold short.

356.9K
0.3%
0.31%
1

Valuation Ratios

The PE ratio is -14.48 and the forward PE ratio is 3.86. Unicycive Therapeutics's PEG ratio is 0.15.

-14.48
3.86
0
1.4
71.57
-18.57
0.15
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Unicycive Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.1.

1.28
1.28
0.1
-0.02
-0.03
-452.35

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1,669,500
22
0
n/a

Taxes

-1.09M
2.89%

Stock Price Statistics

The stock price has increased by 47.9% in the last 52 weeks. The beta is 2, so Unicycive Therapeutics's price volatility has been higher than the market average.

2
47.9%
6.37
5.78
45.43
405,920

Income Statement

n/a
n/a
-32.12M
-36.73M
-36.23M
-37.9M
-0.06
Full Income Statement

Balance Sheet

The company has 26.14M in cash and 773K in debt, giving a net cash position of 25.37M.

26.14M
773K
25.37M
-101.27M
27.95M
10.67M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -28.57M and capital expenditures -72K, giving a free cash flow of -28.65M.

-28.57M
-72K
-28.65M
-0.43
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

UNCY does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for UNCY is $60, which is 901.7% higher than the current price. The consensus rating is "Buy".

$60
901.7%
Buy
3
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Jun 20, 2025. It was a backward split with a ratio of 1:10.

Jun 20, 2025
backward
1:10

Scores

21.11
2